Virological determinants of drug resistance in real-world patients with chronic HCV infection [ 2014 - 2016 ]

Also known as: Virological determinants of drug resistance in chronic HCV infection

Research Grant

[Cite as]

Researchers: Prof Alexander Thompson (Principal investigator) ,  Dr Amanda Aloia A/Pr Michael Beard A/Pr Fabio Luciani A/Pr Gail Matthews
View all 6 related researchers

Brief description New treatments for hepatitis C virus (HCV) infection are emerging. These drugs directly target key events in the viral life cycle. While these drugs are effective, the ability of HCV to mutate means that drug resistance can arise, leading to treatment failure. This is most likely in patients who do not respond to interferon-based therapy. This proposal will use new, highly sensitive sequencing approaches to identify the viral mutations and evolutionary pathways that lead to drug resistance.

Funding Amount $AUD 550,718.01

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]